Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elsa Bernard

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Molecular Informatics|September 27, 2017
Kernel Multitask Regression for ToxicogeneticsElsa Bernard, Yunlong Jiao, Erwan Scornet, et al.
Leukemia & Lymphoma|June 13, 2019
Multifaceted modes of action of azacytidine: a riddle wrapped up in an enigmaEleftheria Lamprianidou, Emmanouela Zoulia, Elsa Bernard, et al.
Plos Biology|October 20, 2017
A molecular atlas of the developing ectoderm defines neural, neural crest, placode, and nonneural progenitor identity in vertebratesJean-Louis Plouhinec, Sofía Medina-Ruiz, Caroline Borday, et al.
Genome Medicine|December 25, 2019
Epigenetic therapy of myelodysplastic syndromes connects to cellular differentiation independently of endogenous retroelement derepressionAnastasiya Kazachenka, George R Young, Jan Attig, et al.
Journal of Internal Medicine|July 10, 2023
Novel precision medicine approaches and treatment strategies in hematological malignanciesRichard Rosenquist, Elsa Bernard, Tom Erkers, et al.
Cancer Discovery|December 2, 2025
Reflections on Advances in Cancer Research in 2025Elsa Bernard, Isidro Cortés-Ciriano, Federico Gaiti, et al.
Blood Cancer Discovery|April 17, 2023
Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid LeukemiaAndriana G Kotini, Saul Carcamo, Nataly Cruz-Rodriguez, et al.
The Lancet. Haematology|December 22, 2023
Predicting cytopenias, progression, and survival in patients with clonal cytopenia of undetermined significance: a prospective cohort studyCatherine Cargo, Elsa Bernard, Tumas Beinortas, et al.
British Journal of Haematology|November 25, 2025
Comorbidities and mutations including single- and multihit TET2 mutations in relation to outcome in chronic myelomonocytic leukaemia-A population-based studyMatilda Kjellander Kynning, Ebba Westerberg, Linda Forsell, et al.
Annals of Internal Medicine|January 20, 2025
Germline <i>UBA1</i> Variant With Somatic Amplification in a Woman With Inflammatory Diseases and Myelodysplastic SyndromeMaria Creignou, Maria Sirenko, Pedro L Moura, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Molecular Informatics|September 27, 2017
Kernel Multitask Regression for ToxicogeneticsElsa Bernard, Yunlong Jiao, Erwan Scornet, et al.
Leukemia & Lymphoma|June 13, 2019
Multifaceted modes of action of azacytidine: a riddle wrapped up in an enigmaEleftheria Lamprianidou, Emmanouela Zoulia, Elsa Bernard, et al.
Plos Biology|October 20, 2017
A molecular atlas of the developing ectoderm defines neural, neural crest, placode, and nonneural progenitor identity in vertebratesJean-Louis Plouhinec, Sofía Medina-Ruiz, Caroline Borday, et al.
Genome Medicine|December 25, 2019
Epigenetic therapy of myelodysplastic syndromes connects to cellular differentiation independently of endogenous retroelement derepressionAnastasiya Kazachenka, George R Young, Jan Attig, et al.
Journal of Internal Medicine|July 10, 2023
Novel precision medicine approaches and treatment strategies in hematological malignanciesRichard Rosenquist, Elsa Bernard, Tom Erkers, et al.
Cancer Discovery|December 2, 2025
Reflections on Advances in Cancer Research in 2025Elsa Bernard, Isidro Cortés-Ciriano, Federico Gaiti, et al.
Blood Cancer Discovery|April 17, 2023
Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid LeukemiaAndriana G Kotini, Saul Carcamo, Nataly Cruz-Rodriguez, et al.
The Lancet. Haematology|December 22, 2023
Predicting cytopenias, progression, and survival in patients with clonal cytopenia of undetermined significance: a prospective cohort studyCatherine Cargo, Elsa Bernard, Tumas Beinortas, et al.
British Journal of Haematology|November 25, 2025
Comorbidities and mutations including single- and multihit TET2 mutations in relation to outcome in chronic myelomonocytic leukaemia-A population-based studyMatilda Kjellander Kynning, Ebba Westerberg, Linda Forsell, et al.
Annals of Internal Medicine|January 20, 2025
Germline <i>UBA1</i> Variant With Somatic Amplification in a Woman With Inflammatory Diseases and Myelodysplastic SyndromeMaria Creignou, Maria Sirenko, Pedro L Moura, et al.
Pageof 6